Article
SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma
28 Feb 2018
Abstract excerpt
An accurate diagnostic marker for detecting early-stage hepatocellular carcinoma (eHCC) is clinically important, since early detection of HCC remarkably improves patient survival. From the integrative analysis of the transcriptome and clinicopathologic data of human multi-stage HCC tissues, we were able to identify barrier-to-autointegration factor 1 (BANF1), procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
